Open Access. Powered by Scholars. Published by Universities.®
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Entire DC Network
The Effects Of Price Regulation On Pharmaceutical R&D And Innovation, Heather M. O'Neill, Lena Clarissa Crain
The Effects Of Price Regulation On Pharmaceutical R&D And Innovation, Heather M. O'Neill, Lena Clarissa Crain
Business and Economics Faculty Publications
As rising health care expenditures focus government attention on slowing the growth, the pharmaceutical industry comes under increasing pressure to curb prices of ethical drugs. Pharmaceutical price regulations have been implemented in many countries to control pharmaceutical expenditures. Yet, creating innovative drugs requires enormous R&D costs, which in turn require adequate expected economic returns. Since price controls reduce profits and expected returns, as countries invoke stricter price regulations, firms will either move their R&D process into less regulated markets or move out of innovative R&D. This paper assesses the impact of drug price regulations in Japan compared to market-priced drugs …
Twentieth Century Economics Of Child-Rearing In Japan, Michele Gibney
Twentieth Century Economics Of Child-Rearing In Japan, Michele Gibney
Michele Gibney
In order to explain the falling Total Fertility Rate (TFR) in Japan, it is necessary to look at the social factors affecting women and raising children in Japan. By examining historical factors surrounding women in Japan—their education, their presence in the workforce, and the cultural stigmas attached to their stereotypical representation—I will attempt to describe the deteriorating TFR in Japan as an economic problem with political and social repercussions. In conclusion I will also try to provide a prognosis and a recommendation for a solution.
Post Merger Performances In Japan, Mami Suzuki
Post Merger Performances In Japan, Mami Suzuki
Honors Papers
Mergers and acquisitions are relatively new phenomena in the Japanese market. The total number M & A transactions per year has increased from approximately 500 to 1,752 between 1995 and 2002. MergerStat records 3,510 and 7,411 transactions in the U.S. for the equivalent years. The percentage of M & A transactions per number of business entities was 0.03% for Japan in 2001 and 0.1% for the U.S. in 2002. As illustrated through the figures, the frequency of M&A in Japan is considerably lower relative to the U.S., but proliferation of transactions is evident as well. Post-merger performances of firms in …